Bivalirudin during and post-percutaneous coronary intervention reduces bleeding and mortality compared to heparin monotherapy
Physician's Weekly,
1. Bivalirudin during percutaneous coronary intervention plus high-dose infusion after demonstrated decreased all-cause…